Does IVOSIDENIB Cause Neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm progression have been filed in association with IVOSIDENIB (TIBSOVO). This represents 1.1% of all adverse event reports for IVOSIDENIB.
18
Reports of Neoplasm progression with IVOSIDENIB
1.1%
of all IVOSIDENIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm progression From IVOSIDENIB?
Of the 18 reports, 2 (11.1%) resulted in death, 2 (11.1%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IVOSIDENIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does IVOSIDENIB Cause?
Off label use (613)
Fatigue (144)
Diarrhoea (100)
Nausea (100)
Disease progression (86)
Differentiation syndrome (80)
Product dose omission issue (68)
Drug ineffective (64)
Platelet count decreased (61)
Electrocardiogram qt prolonged (58)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which IVOSIDENIB Alternatives Have Lower Neoplasm progression Risk?
IVOSIDENIB vs IXABEPILONE
IVOSIDENIB vs IXAZOMIB
IVOSIDENIB vs IXEKIZUMAB
IVOSIDENIB vs JAKAFI
IVOSIDENIB vs JAKAVI